Exam (elaborations)
Oncology Exam 3 2024 Questions with verified correct answers
Oncology Exam 3 2024 Questions with verified correct answers
[Show more]
Content preview
Oncology Exam 3Erlotinib - CORRECT ANSWER-EGFR tyrosine kinase inhibitor
Afatinib - CORRECT ANSWER-EGFR tyrosine kinase inhibitor
Osimertinib - CORRECT ANSWER-EGFR tyrosine kinase inhibitor
Loraltinib - CORRECT ANSWER-EML4-ALK inhibitor
Alectinib - CORRECT ANSWER-EML4-ALK inhibitor
Brigatinib - CORRECT ANSWER-EML4-ALK inhibitor
Pembrolizumab - CORRECT ANSWER-PD-1 inhibitor
Atezolizumab - CORRECT ANSWER-PD-L1 inhibitor
Tremelimumab - CORRECT ANSWER-CTLA4 inhibitor
Cemiplimab - CORRECT ANSWER-PD-1 inhibitor
Nivolumab - CORRECT ANSWER-PD-1 inhibitor
Ipilimumab - CORRECT ANSWER-CTLA4 inhibitor
Crizotinib - CORRECT ANSWER-TRK inhibitor - ROS1 rearrangements
Entrectinib - CORRECT ANSWER-TRK inhibitor - ROS1 rearrangements
Trametinib - CORRECT ANSWER-BRAF V600E inhibitor
Dabrafenib - CORRECT ANSWER-BRAF V600E inhibitor
Capmatinib - CORRECT ANSWER-BRAF V600E inhibitor
Tepotinib - CORRECT ANSWER-BRAF V600E inhibitor
Selpercatinib - CORRECT ANSWER-RET inhibitor
Pralsetinib - CORRECT ANSWER-RET inhibitor
Larotrectinib - CORRECT ANSWER-NTRK inhibitor
, Sotorasib - CORRECT ANSWER-KRAS G12C inhibitor
Bevacizumab - CORRECT ANSWER-VEGF inhibitor
Abiraterone - CORRECT ANSWER-Androgen synthesis inhibitor
Ketoconazole - CORRECT ANSWER-Androgen synthesis inhibitor
Goserelin - CORRECT ANSWER-LHRH agonist
Leuprolide - CORRECT ANSWER-LHRH agonist
Triptorelin - CORRECT ANSWER-LHRH agonist
Degarelix - CORRECT ANSWER-LHRH/GnRH antagonist
Relugolix - CORRECT ANSWER-LHRH/GnRH antagonist
Bicalutamide - CORRECT ANSWER-First generation antiandrogen
Flutamide - CORRECT ANSWER-First generation antiandrogen
Nilutamide - CORRECT ANSWER-First generation antiandrogen
Apalutamide - CORRECT ANSWER-Second generation antiandrogen
Darolutamide - CORRECT ANSWER-Second generation antiandrogen
Enzalutamide - CORRECT ANSWER-Second generation antiandrogen
Olaparib - CORRECT ANSWER-PARP inhibitor
Rucaparib - CORRECT ANSWER-PARP inhibitor
Denosumab - CORRECT ANSWER-RANKL inhibitor
Cabazitaxel - CORRECT ANSWER-Taxane
Durvalumab - CORRECT ANSWER-PD-L1 inhibitor
Etoposide - CORRECT ANSWER-Topoisomerase II inhibitor
Vinorelbine - CORRECT ANSWER-Vinca alkaloid
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller ACTUALSTUDY. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for £6.49. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
62555 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy revision notes and other study material for 14 years now